TREACE MEDICAL CONCEPTS, INC. (TMCI): Price and Financial Metrics
TMCI Price/Volume Stats
Current price | $7.65 | 52-week high | $15.98 |
Prev. close | $7.92 | 52-week low | $3.92 |
Day low | $7.59 | Volume | 311,543 |
Day high | $7.98 | Avg. volume | 827,154 |
50-day MA | $5.63 | Dividend yield | N/A |
200-day MA | $8.27 | Market Cap | 476.57M |
TMCI Stock Price Chart Interactive Chart >
TREACE MEDICAL CONCEPTS, INC. (TMCI) Company Bio
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of device and/or biologic solutions for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was incorporated in 2014 and is headquartered in Ponte Vedra Beach, Florida.
TMCI Price Returns
1-mo | 43.80% |
3-mo | 23.79% |
6-mo | 53.00% |
1-year | -3.77% |
3-year | -62.81% |
5-year | N/A |
YTD | -40.00% |
2023 | -44.54% |
2022 | 23.34% |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...